Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0557 Alone or in Combination for Obesity
NCT00533481Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-0557 in obesity, sponsored by Merck & Co.. Started Feb 2004; status: completed.
02
Drugs
MK-0557
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00533481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533481.